Latest Articles

Subject

Article Type

You have access
Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key
Matt T. Rosenberg, MD, Milton M. Lakin, MD, David R. Staskin, MD, Jeannette Potts, MD and Richard E. Payne, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S63-S71;
You have access
Overactive bladder: Recognition requires vigilance for symptoms
Matt T. Rosenberg, MD, Milton M. Lakin, MD, David R. Staskin, MD, Matt T. Rosenberg, MD, Diane K. Newman, RNC, MSN, CRNP, Christopher T. Tallman, BS and Shari A. Page, CFNP

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S21-S29;
You have access
Interstitial cystitis/painful bladder syndrome: Symptom recognition is key to early identification, treatment
Matt T. Rosenberg, MD, Milton M. Lakin, MD, David R. Staskin, MD, Matt T. Rosenberg, MD, Diane K. Newman, RNC, MSN, CRNP and Shari A. Page, CFNP

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S54-S62;
You have access
Evolving issues in male hypogonadism: Evaluation, management, and related comorbidities
Matt T. Rosenberg, MD, Milton M. Lakin, MD, David R. Staskin, MD, Martin M. Miner, MD and Richard Sadovsky, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S38-S46;
You have access
Benign prostatic hyperplasia: When to ‘watch and wait,’ when and how to treat
Matt T. Rosenberg, MD, Milton M. Lakin, MD, David R. Staskin, MD, Albert Levy, MD and George P. Samraj, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S15-S20;
You have access
Intravenous iodinated contrast agents: Risks and problematic situations
Kimmie L. Bui, MD, Joseph D. Horner, DO, Brian R. Herts, MD and David M. Einstein, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5) 361-367;

Many diagnostic imaging studies use intravenous contrast media. Although these agents are generally safe, they do pose some risk of adverse reactions.
You have access
Screening for urologic malignancies in primary care: Pros, cons, and recommendations
Matt T. Rosenberg, MD, Milton M. Lakin, MD, David R. Staskin, MD, Andrew J. Stephenson, MD, Louis Kuritzky, MD and Steven C. Campbell, MD, PhD

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S6-S14;
You have access
In vitro fertilization update
Jeffrey M. Goldberg, MD, Tommaso Falcone, MD and Marjan Attaran, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5) 329-338;

The science of in vitro fertilization has improved considerably in the last 25 years. We provide an overview of the current and experimental techniques of assisted reproductive technology.
You have access
The recognition of urologic disease is a primary care issue, whether we’ve known it or not
Matt T. Rosenberg, MD, Milton M. Lakin, MD, FACP and David R. Staskin, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5 suppl 3) S5;
You have access
Newer hormonal therapies: Lower doses; oral, transdermal, and vaginal formulations
Mala S. Sivanandy, MD, Nziavake Masimasi, MD and Holly L. Thacker, MD

Cleveland Clinic Journal of Medicine May 2007, 74 (5) 369-375;

We review some of the hormonal regimens that have been approved in the past 5 years.

Main menu

User menu

Search

Latest Articles

Pages

Navigate

Authors & Reviewers